Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes Article

Industry Collaboration International Collaboration

cited authors

  • Pratley, R. E.; Jauffret-Kamel, S.; Galbreath, E.; Holmes, D.

authors

Publication Date

  • June 1, 2006

webpage

published in

category

keywords

  • dipeptidyl peptidase IV
  • efficacy
  • glycemic control
  • incretin

start page

  • 423

end page

  • 428

volume

  • 38

issue

  • 6